PREDICT (Patient characteristics in Renal cell carcinoma and Daily practice Treatment with Nexavar) global non-interventional study: first interim results

被引：0
|
作者：
Jager, D. [1 ]
Ma, J. H. [2 ]
Korbenfeld, E. [3 ]
Zemanova, M. [4 ]
Leonhartsberger, N. [5 ]
Stauch, K. [6 ]
Boeckenhoff, A. [7 ]
Yu, J. [8 ]
Escudier, B. [9 ]
机构：
[1] Univ Heidelberg, Natl Ctr Tumor Dis, Heidelberg, Germany
[2] Peking Union Med Coll, Beijing, Peoples R China
[3] Hosp Britan Buenos Aires, Buenos Aires, DF, Argentina
[4] Charles Univ Prague, Prague, Czech Republic
[5] Univ Innsbruck, A-6020 Innsbruck, Austria
[6] Bayer HealthCare, Leverkusen, Germany
[7] Bayer HealthCare, Wuppertal, Germany
[8] Bayer HealthCare, Montville, NJ USA
[9] Inst Gustave Roussy, Villejuif, France
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)71461-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：431 / 432
页数：2
相关论文
共 50 条
  • [1] PREDICT (Patient Characteristics in REnal Cell Carcinoma and Daily PractICe Treatment With Sorafenib) Non-interventional Study - Final Report
    Jaeger, D.
    Ma, J.
    Korbenfeld, E.
    Zemanova, M.
    Leonhartsberger, N.
    Stauch, K.
    Boeckenhoff, A.
    Yu, J.
    Mardiak, J.
    Escudier, B.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S520 - S520
  • [2] PREDICT (Patient characteristics in REnal cell carcinoma and Daily practICe Treatment with Sorafenib) non-interventional study: subset analysis of patients in Germany
    Jaeger, D.
    Bremer, B.
    Rossi, R.
    Zantl, N.
    Thomalla, J.
    Stauch, K.
    Strauss, U. P.
    Bokenhoff, A.
    Huebner, A.
    Pechoel, M.
    Steiner, T.
    Michel, M. S.
    ONKOLOGIE, 2012, 35 : 235 - 236
  • [3] PREDICT (Patient characteristics in REnal cell carcinoma and Daily practICe Treatment with Sorafenib) Non-interventional study: analysis of special pre-treatment subgroups in the European subset
    Brehmer, B.
    Michel, M. S.
    Rossi, R.
    Zantl, N.
    Thomalla, J.
    Stauch, K.
    Strauss, U. P.
    Bokenhoff, A.
    Huebner, A.
    Pechoel, M.
    Steiner, T.
    Jaeger, D.
    ONKOLOGIE, 2012, 35 : 237 - 238
  • [4] PREDICT (Patient characteristics in REnal cell carcinoma and Daily practICe Treatment with Sorafenib) Non-interventional study: subset analysis of European patients aged ≥ 70 years
    Jaeger, D.
    Michel, M. S.
    Rossi, R.
    Zantl, N.
    Thomalla, J.
    Stauch, K.
    Strauss, U. P.
    Bokenhoff, A.
    Huebner, A.
    Pechoel, M.
    Steiner, T.
    Brehmer, B.
    ONKOLOGIE, 2012, 35 : 238 - 238
  • [5] PREDICT (Patient characteristics in REnal cell carcinoma and Daily practICe Treatment with Sorafenib) non-interventional study: analysis of long versus short-term treatment subgroups in the European subset
    Brehmer, B.
    Michel, M. S.
    Rossi, R.
    Zantl, N.
    Thomalla, J.
    Stauch, K.
    Strauss, U. P.
    Bokenhoff, A.
    Huebner, A.
    Pechoel, M.
    Steiner, T.
    Jaeger, D.
    ONKOLOGIE, 2012, 35 : 236 - 237
  • [6] First subgroup interim analysis of German patients from a global non-interventional study in metastatic renal cell carcinoma patients treated with sorafenib - the PREDICT study
    Jaeger, D.
    Brehmer, B.
    Stauch, K.
    Yu, J.
    ONKOLOGIE, 2010, 33 : 106 - 106
  • [7] Sorafenib treatment of Asian patients with advanced renal cell carcinoma (RCC) in daily practice: Subset analysis of the large non-interventional PREDICT study
    Ye, Dingwei
    Guo, Jun
    Lee, Jae-Lyun
    Zhou, Ai-Ping
    Huang, Yiran
    Hu, Zhiquan
    Fu, Cheng
    Liu, Jiyan
    Qi, Lin
    Li, Hanzhong
    Zou, Qing
    Hong, Sung Joon
    Stauch, Kathrin
    Bockenhoff, Annette
    Kim, Gyunji
    Zhang, XiaoJing
    Ahn, Hanjong
    Ma, Jianhui
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] PATIENT CHARACTERISTICS IN RENAL CELL CARCINOMA AND DAILY PRACTICE TREATMENT WITH SORAFENIB (PREDICT) IN CHINA
    Ye, D-W.
    Guo, J.
    Zhou, A.
    Huang, Y.
    Li, H.
    Hu, Z.
    Fu, C.
    Liu, J.
    Irwin, M.
    Ma, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 453 - 453
  • [9] Sequential treatment with pazopanib followed by nivolumab in patients with renal cell carcinoma: Updated interim results of the non-interventional study PAZOREAL.
    Bedke, Jens
    Boegemann, Martin
    Schostak, Martin
    Hering-Schubert, Christiane
    Welslau, Manfred
    Schleicher, Jan
    Petzoldt, Alexander
    Doehn, Christian
    Gruellich, Carsten
    Goebell, Peter-Juergen
    Steiner, Thomas
    Degenkolbe, Elisa
    Hanson, Sven
    Gruenwald, Viktor
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] USTEKINUMAB FOR THE TREATMENT OF PSORIATIC ARTHRITIS - RESULTS OF THE FIRST INTERIM ANALYSIS OF THE NON-INTERVENTIONAL STUDY SUSTAIN
    Wendler, J.
    Schwarze, I.
    Schwenke, H.
    Behrens, J.
    Gruppe, T.
    Behrens, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1322 - 1322
12345